🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot phase II trial studies ibrutinib in treating patients with trans...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2014-10
Trial ID
NCT02207062
Treatments Being Tested
The purpose of this study is to test the safety of combined use of the stud...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2018-08-23
Trial ID
NCT03581942
Treatments Being Tested
The primary objective of this study is to evaluate the safety of zanubrutin...
Status
Completed
Location
Rocky Mountain Cancer Centers (Williams) Usor
Start Date
2019-10-15
Trial ID
NCT04116437
Treatments Being Tested
The purpose of this study is to assess the potential effects of ketoconazol...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01626651
Treatments Being Tested
This is a multicentre, open-label, phase II study of ibrutinib 560 mg in co...
Status
Unknown
Location
National University Hospital Singapore
Start Date
2016-12-13
Trial ID
NCT02955628
Treatments Being Tested
This phase 2 trial studies ibrutinib to see how well it works in treating p...
Status
Terminated
Location
Stanford University Hospitals and Clinics
Start Date
2015-03
Trial ID
NCT02415608
Treatments Being Tested
Ibrutinib is an irreversible Bruton tyrosine-kinase inhibitor. In prospecti...
Status
Completed
Location
Sestre milosrdnice University Hospital
Start Date
2018-12-01
Trial ID
NCT03751410
This phase IIa trial studies the side effects and how well TGR-1202 and ibr...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2016-10-07
Trial ID
NCT02874404
Treatments Being Tested
The study is an open label, prospective, multicenter, phase II study which ...
Status
Completed
Location
CHU d'ESTAING
Start Date
2015-09
Trial ID
NCT02542514
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested